85 related articles for article (PubMed ID: 3600195)
1. Opiate system involvement in the control of LH secretion in diabetic and normoglycemic male rats.
Yogev L; Gottreich A; Brezner E; Paz GF; Homonnai ZT
Life Sci; 1987 Aug; 41(5):585-90. PubMed ID: 3600195
[TBL] [Abstract][Full Text] [Related]
2. Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin.
Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
Life Sci; 1994; 54(4):261-6. PubMed ID: 8289586
[TBL] [Abstract][Full Text] [Related]
3. Changes in LH and prolactin levels in diabetic male rats and the role of the opiate system in the control of their secretion.
Yogev L; Gottriech A; Timan B; Homonnai ZT; Paz GF
Life Sci; 1985 Sep; 37(11):993-9. PubMed ID: 4033351
[TBL] [Abstract][Full Text] [Related]
4. Possible dopaminergic system involvement in LH and PRL responses to naltrexone treatment.
Yogev L; Gottreich A; Homonnai ZT; Paz GF
Life Sci; 1989; 45(24):2343-9. PubMed ID: 2601582
[TBL] [Abstract][Full Text] [Related]
5. Luteinizing hormone secretion as a response to a second naltrexone administration.
Yogev L; Gottreich A; Homonnai ZT; Yavetz H; Paz GF
Proc Soc Exp Biol Med; 1990 Oct; 195(1):22-5. PubMed ID: 2399258
[TBL] [Abstract][Full Text] [Related]
6. Serum prolactin response to ether stress in diabetic rats: opiate system contribution.
Yogev L; Yavetz H; Gottreich A; Oppenheim D; Homonnai ZT; Paz G
Proc Soc Exp Biol Med; 1994 Mar; 205(3):248-52. PubMed ID: 8171046
[TBL] [Abstract][Full Text] [Related]
7. Naltrexone-induced LH release in ovariectomized estrogen-primed rats.
Higuchi T; Kawakami M
Endocrinol Jpn; 1981 Feb; 28(1):45-50. PubMed ID: 7250068
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LH concentrations in the male rat.
Briski KP; Quigley K; Meites J
Life Sci; 1984 Jun; 34(25):2485-93. PubMed ID: 6374352
[TBL] [Abstract][Full Text] [Related]
9. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
[TBL] [Abstract][Full Text] [Related]
10. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
Leadem CA; Kalra SP
Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
[TBL] [Abstract][Full Text] [Related]
11. Counteraction by naltrexone of stress-induced inhibition of TSH release: role of noradrenergic system.
Briski K; Quigley K; Meites J
Proc Soc Exp Biol Med; 1984 Nov; 177(2):354-9. PubMed ID: 6091150
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of naltrexone on luteinizing hormone release during single versus repetitive exposure to restraint stress.
Briski KP; Sylvester PW
Psychoneuroendocrinology; 1992; 17(2-3):125-33. PubMed ID: 1332097
[TBL] [Abstract][Full Text] [Related]
13. Effects of hyperprolactinemia on the control of luteinizing hormone and follicle-stimulating hormone secretion in the male rat.
Smith MS; Bartke A
Biol Reprod; 1987 Feb; 36(1):138-47. PubMed ID: 3105612
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic effects of the new opioid antagonist naltrexone-estrone azine on pituitary luteinizing hormone secretion in ovariectomized rats.
Armeanu MC; van Dieten JA; Kolb VM; Schoemaker J; de Koning J
Life Sci; 1992; 50(13):913-21. PubMed ID: 1548976
[TBL] [Abstract][Full Text] [Related]
15. Concomitant inhibition of pulsatile luteinizing hormone (LH) and stimulation of prolactin release by prostacyclin (PGI2) in ovariectomized (OVX) conscious rats.
Ottlecz A; McCann SM
Life Sci; 1988; 43(25):2077-85. PubMed ID: 3062293
[TBL] [Abstract][Full Text] [Related]
16. Opioid regulation of luteinizing hormone secretion in the male rat.
Miller MA; Bremner WJ; Clifton DK; Dorsa DM; Steiner RA
Biol Reprod; 1986 Aug; 35(1):17-26. PubMed ID: 3741948
[TBL] [Abstract][Full Text] [Related]
17. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
Fox SR; Hoefer MT; Bartke A; Smith MS
Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
[TBL] [Abstract][Full Text] [Related]
18. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone-reversible.
Van Vugt DA; Baby N; Stewart M; Reid RL
Neuroendocrinology; 1989 Jul; 50(1):109-16. PubMed ID: 2755561
[TBL] [Abstract][Full Text] [Related]
19. Delayed suppression of serum luteinizing hormone after naloxone treatment in neonatal female rats.
Field EA; Kuhn CM
Life Sci; 1989; 44(26):2025-32. PubMed ID: 2747414
[TBL] [Abstract][Full Text] [Related]
20. Differential gonadotropin responses to N-methyl-D,L-aspartate in metestrous, proestrous, and ovariectomized rats.
Luderer U; Strobl FJ; Levine JE; Schwartz NB
Biol Reprod; 1993 Apr; 48(4):857-66. PubMed ID: 8485252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
